Targeting of ibrutinib resistance-driving pathways by miR-28 in ABC-DLBCL.
Saved in:
| Title: | Targeting of ibrutinib resistance-driving pathways by miR-28 in ABC-DLBCL. |
|---|---|
| Authors: | Álvarez-Corrales E; Department of Immunology, Ophthalmology and ENT, Universidad Complutense de Madrid, Madrid, Spain.; Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain., Moreno-Palomares R; Department of Immunology, Ophthalmology and ENT, Universidad Complutense de Madrid, Madrid, Spain.; Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain., Gómez-Escolar C; B Cell Biology Lab. Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.; Instituto de Neurociencias de Alicante (CSIC), Alicante, Spain., Martínez M; Instituto Madrileño de Estudios Avanzados en Nanociencia (IMDEA Nanociencia), Madrid, Spain., Moral-Pérez U; Department of Immunology, Ophthalmology and ENT, Universidad Complutense de Madrid, Madrid, Spain.; Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain., Laguna-Herrero M; Department of Immunology, Ophthalmology and ENT, Universidad Complutense de Madrid, Madrid, Spain., Fuertes T; Department of Immunology, Ophthalmology and ENT, Universidad Complutense de Madrid, Madrid, Spain.; B Cell Biology Lab. Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.; Department of Pharmacy and Nutrition, Faculty of Biomedical and Health Sciences, Universidad Europea de Madrid, Madrid, Spain., Estrada BS; Interactions with the environment program, Centro de Biología Molecular Severo Ochoa (CBMSO), CSIC-UAM, Madrid, Spain; Intestinal Morphogenesis and Homeostasis Group, Area 3-Cancer, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., Mur S; B Cell Biology Lab. Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain., de Bonis A; Department of Immunology, Ophthalmology and ENT, Universidad Complutense de Madrid, Madrid, Spain., Leiva M; Department of Immunology, Ophthalmology and ENT, Universidad Complutense de Madrid, Madrid, Spain., Martínez-Martín N; Interactions with the environment program, Centro de Biología Molecular Severo Ochoa (CBMSO), CSIC-UAM, Madrid, Spain; Intestinal Morphogenesis and Homeostasis Group, Area 3-Cancer, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., Somoza Á; Instituto Madrileño de Estudios Avanzados en Nanociencia (IMDEA Nanociencia), Madrid, Spain., Ramiro AR; B Cell Biology Lab. Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain., de Yébenes VG; Department of Immunology, Ophthalmology and ENT, Universidad Complutense de Madrid, Madrid, Spain. vgarciay@ucm.es.; Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain. vgarciay@ucm.es. |
| Source: | Leukemia [Leukemia] 2026 May; Vol. 40 (5), pp. 894-905. Date of Electronic Publication: 2026 Apr 08. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
